HyperCVAD regimen
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HyperCVAD regimen, covering 2013-12-10 to 2013-12-10. Get the full timeline:
Most recent: Clinical Trial Update: Rituximab-HyperCVAD (R-HCVAD) Alternating With Rituximab-Methotrexate-Cytarabine- (R-MC) in Newly Diagnosed Patients With Diffuse Large B-Cell Lymphoma With MYC-Rearrangement. [Phase 2]